Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mimi, Tesfaye"'
Autor:
Hongbo, Yang, Vamsi, Bollu, Stephen, Lim, Mimi, Tesfaye, Anand A, Dalal, Angela, Lax, Sakshi, Sethi, Jing, Zhao
Publikováno v:
Leukemia & Lymphoma. 64:339-348
Chimeric antigen receptor T-cell (CAR-T) infusion settings may impact healthcare resource use (HRU) and reimbursement amounts. Adults with diffuse large B-cell lymphoma receiving CAR-T therapy were identified from the Centers for MedicareMedicaid Ser
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b2f5e6395641e59d8acac0a9b141791
https://doi.org/10.1080/10428194.2022.2147395
https://doi.org/10.1080/10428194.2022.2147395
Autor:
Jing Zhao, Stephen Lim, Vamsi Bollu, Hongbo Yang, Qiufei Ma, Angela Lax, Mimi Tesfaye, Anand A. Dalal
Publikováno v:
Journal of Clinical Oncology. 39:e19550-e19550
e19550 Background: Axicabtagene ciloleucel (axi-cel) and tisagenlecleucel (tisa-cel) are CAR-T therapies that were approved for r/r DLBCL in 2017 and 2018, respectively. While majority of the CAR-T infusions occur at inpatient (IP) setting in clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2ac3ca8b987b9c9ba100785364680df
https://doi.org/10.1200/jco.2021.39.15_suppl.e19550
https://doi.org/10.1200/jco.2021.39.15_suppl.e19550
Autor:
Yang, Hongbo1 (AUTHOR) hongbo.yang@analysisgroup.com, Bollu, Vamsi2 (AUTHOR), Lim, Stephen2 (AUTHOR), Tesfaye, Mimi2 (AUTHOR), Dalal, Anand A.2 (AUTHOR), Lax, Angela1 (AUTHOR), Sethi, Sakshi1 (AUTHOR), Zhao, Jing1 (AUTHOR)
Publikováno v:
Leukemia & Lymphoma. Feb2023, Vol. 64 Issue 2, p339-348. 10p.
Publikováno v:
Medical Letter on the CDC & FDA; 7/14/2023, p948-948, 1p